IP Library Granted Patent US 8,911,963
Granted Patent B2
US 8,911,963 · App. 13/639,380 · Granted Dec 16, 2014

Conditioned medium obtained from stem cells and its use in therapy

Inventors: Stephen E. Epstein (Rockville, MD); Mary Susan Burnett (Burke, VA); Amir Najafi (Potomac, MD)
Assignee: MedStar Health Research Institute, Inc.
A61K38/1891A61K35/28A61L27/3895A61B17/50A61L27/3834A61L27/60A61K35/35
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,911,963
App. No.
13/639,380
Granted
Dec 16, 2014
Kind
B2
Abstract

Described herein are conditioned medium and processed conditioned medium, each of which comprises secreted stem cell factors; compositions containing conditioned medium and/or processed conditioned medium and a delivery polymer. The conditioned medium, processed conditioned medium and compositions may be used to promote blood vessel growth and healing of injured tissues.

Claims (13)

1. A method of producing processed conditioned medium, comprising:

(a) culturing stem cells in growth-factor-free medium comprising desferroxamine, wherein the stem cells have been previously cultured in growth medium, thereby generating conditioned medium that comprises factors secreted by the stem cells;

(b) harvesting the conditioned medium; and

(c) filtering the conditioned medium to produce processed conditioned medium.

2. The method of claim 1 , wherein the filtering is by ultra-filtration.

3. The method of claim 1 , wherein the processed conditioned medium comprises an increased concentration of angiogenic factors.

4. The method of claim 1 , wherein the stem cells are isolated from bone marrow or adipose tissue.

5. The method of claim 4 , wherein the stem cells are isolated from bone marrow and are mesenchymal stem cells.

6. The method of claim 4 , wherein the stem cells are isolated from bone marrow and are hematopoietic stem cells.

7. A method of enhancing secretion of angiogenic factors by stem cells, comprising culturing the stem cells in growth factor-free medium comprising desferroxamine.

8. The method of claim 7 , wherein the stem cells are isolated from bone marrow or adipose tissue.

9. The method of claim 8 , wherein the stem cells are isolated from bone marrow and are mesenchymal stem cells.

10. The method of claim 8 , wherein the stem cells are isolated from bone marrow and are hematopoietic stem cells.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2013
From: EPSTEIN, STEPHEN E.; BURNETT, MARY SUSAN; NAJAFI, AMIR
To: MEDSTAR HEALTH RESEARCH INSTITUTE, INC.
Reel/Frame 029647/0217 →
Continuity (1)
Related Publication 20130110132A1 · May 2, 2013